Home › Compare › TKCM vs JNJ

TKCM vs JNJ: Dividend Comparison 2026

TKCM yields 20000.00% · JNJ yields 2.14%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 TKCM wins by $52481917574412746752.00M in total portfolio value
10 years
TKCM
TKCM
● Live price
20000.00%
Share price
$0.01
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$52481917574412746752.00M
Annual income
$51,970,745,957,167,775,000,000,000.00
Full TKCM calculator →
JNJ
Johnson & Johnson
● Live price
2.14%
Share price
$242.49
Annual div
$5.20
5Y div CAGR
28%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$30.5K
Annual income
$4,749.88
Full JNJ calculator →

Portfolio growth — TKCM vs JNJ

📍 TKCM pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodTKCMJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, TKCM + JNJ cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
TKCM pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

TKCM
Annual income on $10K today (after 15% tax)
$1,700,000.00/yr
After 10yr DRIP, annual income (after tax)
$44,175,134,063,592,610,000,000,000.00/yr
JNJ
Annual income on $10K today (after 15% tax)
$182.28/yr
After 10yr DRIP, annual income (after tax)
$4,037.40/yr
At 15% tax rate, TKCM beats the other by $44,175,134,063,592,610,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of TKCM + JNJ for your $10,000?

TKCM: 50%JNJ: 50%
100% JNJ50/50100% TKCM
Portfolio after 10yr
$26240958787206373376.00M
Annual income
$25,985,372,978,583,888,000,000,000.00/yr
Blended yield
99.03%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

TKCM
No analyst data
Altman Z
0.7
Piotroski
3/9
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
-5.7% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

TKCM buys
0
JNJ buys
0
No recent congressional trades found for TKCM or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricTKCMJNJ
Forward yield20000.00% ✓2.14%
Annual dividend / share$2.00$5.20 ✓
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%28% ✓
Portfolio after 10y$52481917574412746752.00M ✓$30.5K
Annual income after 10y$51,970,745,957,167,775,000,000,000.00 ✓$4,749.88
Total dividends collected$52448189483771600896.00M ✓$15.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: TKCM vs JNJ ($10,000, DRIP)

YearTKCM PortfolioTKCM Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$2,010,700$2,000,000.00$10,594$274.49+$2.00M → TKCM
2$377,983,225$375,831,775.70$11,294$360.69+$377.97M → TKCM
3$66,433,479,469$66,029,037,418.28$12,133$476.91+$66433.47M → TKCM
4$10,916,985,471,987$10,845,901,648,955.73$13,156$635.42+$10916985.46M → TKCM
5$1,677,384,363,769,318$1,665,703,189,314,291.80$14,432$854.61+$1677384363.75M → TKCM
6$240,985,175,079,139,100$239,190,373,809,905,920.00$16,056$1,162.76+$240985175079.12M → TKCM
7$32,373,573,631,143,694,000$32,115,719,493,809,017,000.00$18,175$1,604.53+$32373573631143.68M → TKCM
8$4,066,766,648,320,630,000,000$4,032,126,924,535,306,000,000.00$21,009$2,252.68+$4066766648320630.00M → TKCM
9$477,730,483,406,513,300,000,000$473,379,043,092,810,300,000,000.00$24,911$3,229.73+$477730483406513344.00M → TKCM
10$52,481,917,574,412,750,000,000,000$51,970,745,957,167,775,000,000,000.00$30,458$4,749.88+$52481917574412746752.00M → TKCM

TKCM vs JNJ: Complete Analysis 2026

TKCM — Stock

Token Communities, Ltd. operates as a real estate development company. It has approximately 20 premium waterfront home sites that include gulf-access properties with boat docks in Sarasota County, Charlotte County, and other locations, as well as office suites in Manatee County. The company holds the development rights for Paradise Island in Arcadia, Florida, located in DeSoto County. It also works on an Asia Pacific Opportunity Zone (APOZ) project of approximately 500 acres in the Greater Houston Area, specifically in Chambers County, which consist of industrial, commercial, and residential areas. In addition, the company engages in a revolutionary affordable housing development project in the Palm Bay Area, located in Brevard County, Florida, and Chambers County, Texas. The company was incorporated in 2014 and is based in Bradenton, Florida. Token Communities Ltd. operates as a subsidiary of American Software Capital, Inc. real estate development company.

Full TKCM Calculator →

JNJ — Healthcare

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.

Full JNJ Calculator →
📬

Get this TKCM vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

TKCM vs SCHDTKCM vs JEPITKCM vs OTKCM vs KOTKCM vs MAINTKCM vs ABBVTKCM vs MRKTKCM vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.